CLIMB BIO INC. - COMM
3.5200
07-11月-24 15:59:59
15 分の遅延
株式
-0.1300
-3.56%
本日の幅
3.4900 - 3.7850
ISIN
N/A
ソース
NASDAQ
-
Eliem Therapeutics Reports Second Quarter Financial and Business Highlights
15 8 2022 06:10:00 提供 Nasdaq GlobeNewswire
-
Eliem Therapeutics Provides ETX-810 Program Update
02 8 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
18 7 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
Eliem Therapeutics to Host Virtual Investor Event on July 21, 2022
07 7 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
27 6 2022 16:01:00 提供 Nasdaq GlobeNewswire
-
Eliem Therapeutics Reports First Quarter Financial and Business Highlights
16 5 2022 06:10:00 提供 Nasdaq GlobeNewswire
-
Eliem Provides Update on ETX-810 and ETX-155 Clinical Programs
25 4 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
Eliem Therapeutics Appoints Susan Franks as Senior Vice President and Head of Regulatory Affairs
05 4 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
Eliem Therapeutics to Present at Stifel’s 2022 CNS Days
21 3 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
Eliem Therapeutics Reports Fourth Quarter and Year-End Financial and Business Highlights
07 3 2022 16:10:00 提供 Nasdaq GlobeNewswire
-
Eliem Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
11 2 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
07 2 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
Eliem Therapeutics Provides Program Updates and an Overview of Expected Near-Term Milestones
18 1 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
Eliem Therapeutics Reports Third Quarter Financial and Business Highlights
08 11 2021 16:01:00 提供 Nasdaq GlobeNewswire
-
Eliem Therapeutics to Participate at Four Upcoming Investor Conferences
04 11 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
Eliem Therapeutics Reports Second Quarter Financial Results
13 9 2021 16:10:00 提供 Nasdaq GlobeNewswire
-
12 8 2021 21:06:11 提供 Nasdaq GlobeNewswire
-
Eliem Therapeutics Announces Pricing of Initial Public Offering
09 8 2021 22:33:09 提供 Nasdaq GlobeNewswire